RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$94.29
-1.23 (-1.29%)
Performance
1D
—
1W
—
1M
—
3M
+16.77%
6M
+104.67%
1Y
+149.97%
YTD
+19.32%
Open$96.54
Previous Close$95.52
Day High$97.37
Day Low$92.59
52W High$124.49
52W Low$29.17
Volume—
Avg Volume1.74M
Market Cap19.86B
P/E Ratio—
EPS$-2.73
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$94.85
Below
SMA 200
$58.23
Above
RSI (14)
62.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
+21.0% upside
Current
$94.29
$94.29
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |